Table 1.

Effectiveness of different doses of compound 3 and APX3330 in reducing IgA switching of CH12F3 cells.

	Compound 3			APX3330
Dose (μm)	0.04	0.2	1	2.5	12.5	50
IgA reduction (%)	5 ± 2.6	12 ± 1.9	25 ± 5.9	0.5 ± 2.5	7 ± 3.5	31 ± 8